November 20th, 2024Program Wednesday

Congress hall
08:30–09:45 am

Improving stroke outcome
Selected from submitted abstracts

Conference room
08:30–09:45 am

Inflammation and the brain 2: therapeutic approaches
Selected from submitted abstracts

Meeting room
08:30–09:45 am

Novel concepts for optimization of therapeutic approaches
Selected from submitted abstracts

09:45-10:30 am | Coffee break

Congress hall
10:30 am–12:00 pm

Tissue-type Plasminogen Activator (tPA): Beyond Fibrinolysis

Conference room
10:30 am–12:00 pm

Hemorrhagic stroke II: novel models and mechanisms
Selected from submitted abstracts

Meeting room
10:30 am–12:00 pm

Neuroprotection and immunomodulation for stroke in post-thrombectomy era

12:00-01:00 pm | Lunch break
01:00–02:30 pm | Poster viewing

Congress hall
02:30–04:00 pm

Defining a role for the immune system in stroke: preclinical and clinical evidence

Conference room
02:30–04:00 pm

Mesenchymal Stem Cell-derived Extracellular Vesicles: a Potential New Tool for Cerebral Ischemia

Meeting room
02:30–04:00 pm

Early brain perturbations contribute to long–term brain aging

04:00-04:30 pm | Coffee break

Congress hall
04:30–05:30 pm

ISN&N closing session

Status: August 2024